BEUDAMED
    9 results · 35ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    SANPO I

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    BT HYPODERMIC SYRINGE

    FDA 510(k)
    FDA Class 2 ·General Hospital

    LABELING SUBMITTAL, ADX TM CANNABINOIDS-GS

    FDA 510(k)
    FDA Class 2 ·Clinical Toxicology

    ATTAIN OTW

    FDA Adverse Event
    Injury ·MPRI·Product code LWP·February 15, 2013

    PRECISION TEST STRIPS

    FDA Adverse Event
    Malfunction ·ABBOTT DIABETES CARE, INC. USA·Product code NBW·January 20, 2011

    G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

    FDA Adverse Event
    Malfunction ·DEXCOM, INC.·Product code MDS·July 29, 2014

    CONTOUR ACETABULAR RECONSTRUCTION RING

    FDA Adverse Event
    Injury ·SMITH & NEPHEW, INC.·Product code JDJ·June 6, 2025

    MESH, SURGICAL, ACETABULAR, HIP, PROSTHESIS

    FDA Adverse Event
    Injury ·SMITH & NEPHEW, INC.·Product code JDJ·January 23, 2026

    Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017